Today: 30 June 2026
Strategy Inc stock slides after hours as bitcoin slips and a fresh MSTR target cut lands
9 January 2026
1 min read

Strategy Inc stock slides after hours as bitcoin slips and a fresh MSTR target cut lands

New York, Jan 9, 2026, 16:41 ET — After-hours

  • Strategy shares fell about 6% in after-hours trading, tracking a softer bitcoin.
  • Clear Street cut its price target on the stock while keeping a buy rating.
  • Investors keep a close eye on index-rule changes that could affect passive demand for bitcoin-treasury firms.

Strategy Inc (MSTR.O) shares were down 5.8% at $157.33 in after-hours trade on Friday, after sliding as low as $155.51 earlier in the day. Bitcoin fell 0.9% to $90,356.

The move matters because Strategy trades less like a software firm these days and more like a high-beta bet on bitcoin, with swings that can dwarf the token’s day-to-day moves. It also comes as investors keep revisiting how index providers treat “digital asset treasury” stocks — a corner of the market that can live or die on passive flows. Reuters

MSCI, which runs widely tracked stock indexes, said it would keep digital-asset treasury companies in its global benchmarks for now after a consultation, but it added constraints that bite in a different way. MSCI said it will not raise the “number of shares” it uses for index weights for those names — in plain terms, new shares issued would not lift their weight in MSCI indexes. MSCI

Clear Street analyst Brian Dobson cut his price target on Strategy to $268 from $443 on Friday, but kept a “buy” rating. Dobson called Strategy a “differentiated” way to get “leveraged Bitcoin exposure,” while noting that the stock is now trading closer to some measures of the value of its bitcoin per share. Investing.com

In a Jan. 5 regulatory filing, Strategy said it held 673,783 bitcoin as of Jan. 4 and had built a $2.25 billion U.S. dollar reserve to support dividend and interest payments. The same filing flagged a $17.44 billion fourth-quarter unrealized loss on digital assets, a reminder that accounting swings can still hit reported results even when the market is focused on the coin price.

That mix leaves the stock tethered to bitcoin’s tape and to the mechanics of how it funds itself. Strategy has repeatedly tapped capital markets to add to its bitcoin position, so anything that curbs index-driven buying or lifts the cost of funding can show up fast in the share price.

But the setup cuts both ways. A bitcoin rebound can lift Strategy quickly, while a deeper slide in the token — or another round of index scrutiny later this year — could pressure the stock again, especially if investors start pricing in more dilution from future share sales.

Traders now look to bitcoin’s hold above the $90,000 area and to the next set of corporate markers: Strategy is slated to report earnings on Feb. 3, according to Investing.com.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • AbbVie (NYSE:ABBV) Jumps After Apogee Deal, New Drug Approvals
    June 30, 2026, 2:12 PM EDT. AbbVie shares climbed almost 11% last week, adding around $43 billion to its market cap. The move came after AbbVie's $10.9 billion Apogee Therapeutics buyout, which is meant to build up its immunology lineup against Sanofi and Regeneron's Dupixent. Skyrizi picked up expanded approval for pediatric psoriasis, and in Europe, a panel backed new uses for Rinvoq, setting up more market opportunities. AbbVie is also counting on growth from its neuroscience and oncology units, with the Parkinson's drug Vyalev and cancer therapy Decnupaz in focus. AbbVie trades at a lower P/E than sector rivals, which some investors say is attractive given its lineup and deals.
Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14
Previous Story

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14

Lululemon stock drops nearly 4% as tariff ruling stays unresolved — what to watch next
Next Story

Lululemon stock drops nearly 4% as tariff ruling stays unresolved — what to watch next

Go toTop